Stryker’s newly FDA-cleared Incompass® Total Ankle System marks a significant advancement in orthopedic innovation, combining the strengths of the company’s previous Inbone® and Infinity® systems into one cohesive platform. Developed using over 85,000 CT scans and 100,000 clinical cases, the system incorporates Adaptis® Boney Ingrowth Technology, offering enhanced fixation and anatomical alignment. Built on Stryker’s SOMA (Stryker Orthopaedic Modeling & Analytics) platform, Incompass leverages detailed data insights and surgical planning capabilities to deliver a new level of precision and adaptability in total ankle replacement.

The Incompass system is designed to address long-standing challenges in total ankle arthroplasty, including intraoperative flexibility and workflow optimization. With updated implant holders, a redesigned alignment system, and streamlined instrumentation, surgeons gain improved control across multiple planes and reduced procedural complexity. These features enable faster setup times, customizable implant selection, and a more patient-specific approach—making it ideal for treating severe degenerative, post-traumatic, or rheumatoid arthritis of the ankle joint.